Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion type Assertion NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_head.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion description "[These findings suggest that novel drugs to antagonize PPARalpha, other than the PPARgamma signalling system, may also need to be considered in the treatment or prevention of Graves' ophthalmopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion evidence source_evidence_literature NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion SIO_000772 15291748 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion wasDerivedFrom befree-2016 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion wasGeneratedBy ECO_0000203 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.